BioStem Technologies Reports Fourth Quarter Revenue of $11.5 Million, 14-Fold YoY Increase
April 01, 2024 16:05 ET
|
Biostem Technologies
BioStem Technologies Reports Fourth Quarter Revenue of $11.5 Million, 14-Fold YoY Increase
BioStem Technologies to Report Fourth Quarter 2023 Financial Results on Monday, April 01, 2024
March 21, 2024 08:00 ET
|
Biostem Technologies
BioStem Technologies to Report Fourth Quarter 2023 Financial Results on Monday, April 01, 2024
PRISM MarketView Spotlights BioStem Technologies in the Expanding Wound Care Market
February 26, 2024 10:39 ET
|
PRISM MarketView
PRISM MarketView Highlights BioStem Technologies as it Targets Significant Opportunity in Wound Care Markets
Amniowrap2™ Product Launch Leads Year of Highlights for BioStem Technologies
January 30, 2024 16:05 ET
|
Biostem Technologies
Amniowrap2™ Product Launch Leads Year of Highlights for BioStem Technologies
BioStem Technologies Appoints Proven Life Science Sales Leader Shawn McCarrey to Chief Commercial Officer Role
January 11, 2024 08:30 ET
|
Biostem Technologies
BioStem Technologies Appoints Proven Life Science Sales Leader Shawn McCarrey to Chief Commercial Officer role
BioStem Technologies Appoints Executive Leader Patrick Daly to Board of Directors
December 19, 2023 08:30 ET
|
Biostem Technologies
BioStem Technologies Appoints Executive Leader Patrick Daly to Board of Directors
Center for Medicare Services Established National Pricing of AmnioWrap2™ in All MAC Regions
December 14, 2023 08:30 ET
|
Biostem Technologies
The Center for Medicare Services (CMS) has established national pricing for AmnioWrap2(TM) in all Medicare Administrative Contractors (MAC) regions
BioStem Technologies, Inc. Awarded Q Code for VENDAJE® Product Line From CMS.
July 23, 2021 09:00 ET
|
BioStem Technologies, Inc.
Pompano Beach, Fl., July 23, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a pre-clinical-stage biotechnology company focused on harnessing...
BioStem Technologies, Inc. Announces Launch of National Sales Force Expansion
April 15, 2021 09:00 ET
|
BioStem Technologies, Inc.
Pompano Beach, Fl., April 15, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a pre-clinical-stage biotechnology company focused on harnessing...
BioStem Technologies, Inc. Reports Financial Results for Fourth Quarter and Fiscal Year 2020
April 05, 2021 09:00 ET
|
BioStem Technologies, Inc.
Pompano Beach, Fl., April 05, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a leading pre-clinical-stage biotechnology company focused on...